
Haleon Spon Ads Each Rep 2 Ord Shs Aktie (HLN)
Börsennotiertes Unternehmen. Hier finden Sie den Kurs, einen Überblick über das Geschäft und das Wichtigste zu Haleon Spon Ads Each Rep 2 Ord Shs im September 2026.
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and others. The Company's segments include North America, Europe, Asia Pacific, and International. Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
Über diese Aktie
HALEON PLC SPON ADS EACH REP 2 ORD SHS
HLN
Aktueller Kurs
$9.20
Potenzieller Gewinn auf 12 Monate
15.93%
Sektor
Gesundheitswesen
Branche
Pharma
Ticker
HLN
Marktkapitalisierung
$39.66B
Potenzieller Gewinn auf 12 Monate
15.93%
Sektor
Gesundheitswesen
Branche
Pharma
Wertentwicklung über 6 Monate
Kursentwicklung im Überblick
Analystenbewertung
Analysts recommend buying Haleon’s stock with a target price of $10.9, indicating growth potential.
Finanzielle Gesundheit
Haleon is generating strong revenue and profits, with solid cash flow supporting its operations.
Dividende
Haleon's projected dividend yield of 1.33% is below average, which may not attract income-focused investors. If you invested $1000 you would be paid $13.30 a year in dividends (based on the last 12 months).
Warum mit Nemo investieren?
Ohne Provision
Handeln Sie Aktien, ETFs und mehr ohne Provision. Behalten Sie mehr von Ihrer Rendite.
Vertrauenswürdig & reguliert
Seit 2015 Teil der Exinity Group, mit über einer Million Kunden weltweit.